Why is Shandong Sito Bio-technology Co., Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 1.18% and Operating profit at -188.91% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
The company has declared Negative results for the last 7 consecutive quarters
- PRE-TAX PROFIT(Q) At CNY -18.99 MM has Fallen at -3,270.3%
- NET PROFIT(Q) At CNY -16.54 MM has Fallen at -1,199.98%
- ROCE(HY) Lowest at -9.31%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -51.39%, its profits have fallen by -3210.7%
- At the current price, the company has a high dividend yield of 0.1
4
Below par performance in long term as well as near term
- Along with generating -51.39% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shandong Sito Bio-technology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shandong Sito Bio-technology Co., Ltd.
-48.35%
0.07
36.56%
China Shanghai Composite
13.33%
0.90
14.74%
Quality key factors
Factor
Value
Sales Growth (5y)
1.18%
EBIT Growth (5y)
-188.91%
EBIT to Interest (avg)
-0.06
Debt to EBITDA (avg)
5.40
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.40
Tax Ratio
2.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.65%
ROE (avg)
1.52%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.61
EV to EBIT
-20.94
EV to EBITDA
1250.02
EV to Capital Employed
1.46
EV to Sales
3.85
PEG Ratio
NA
Dividend Yield
0.12%
ROCE (Latest)
-6.96%
ROE (Latest)
-9.76%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
5What is working for the Company
NET PROFIT(HY)
Higher at CNY -41.72 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.53 times
NET SALES(Q)
At CNY 241.43 MM has Grown at 21.7%
-19What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY -18.99 MM has Fallen at -3,270.3%
NET PROFIT(Q)
At CNY -16.54 MM has Fallen at -1,199.98%
ROCE(HY)
Lowest at -9.31%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.12 times
RAW MATERIAL COST(Y)
Grown by 41.38% (YoY
Here's what is working for Shandong Sito Bio-technology Co., Ltd.
Net Sales
At CNY 241.43 MM has Grown at 21.7%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Inventory Turnover Ratio
Highest at 1.53 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Shandong Sito Bio-technology Co., Ltd.
Pre-Tax Profit
At CNY -18.99 MM has Fallen at -3,270.3%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -16.54 MM has Fallen at -1,199.98%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 2.12 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 41.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






